Evidence-based psychopharmacology 2. Appraising a systematic review: is risperidone better than conventional antipsychotics in the treatment of schizophrenia?

Abstract

Systematic reviews are increasingly used to combine the results of several studies in order to define the treatment effect with a high degree of precision. However, reviews of this nature may lead to spurious results and should not be accepted uncritically. This article, the second in a series on evidence-based psychopharmacology, is intended to illustrate the process of critical appraisal of a systematic review. In this example, a systematic review of studies comparing risperidone with conventional antipsychotics is appraised. Interpretation of the results of the systematic review may be hampered by the way in which studies were selected.

Keywords

antipsychotic critical appraisal evidence-based medicine meta-analysis risperidone

Get full access to this article

View all access options for this article.

References

Bailar JC (1997) The promise and problems of meta-analysis. N Engl J Med 337: 536–542

Bondolfi G , Baumann P , Patris M et al. (1995) A randomised doubleblind trial of risperidone versus clozapine for treatment resistant chronic schizophrenia (abstract). International Academy for Biomedical Research, Florence

Egger M , Davey-Smith G (1998) Meta-analysis. Bias in location and selection of studies. BMJ 316: 61–66

Egger M , Davey-Smith G , Phillips A (1997) Meta-analysis. Principles and procedures. BMJ 315:1533–1537

Mitchell A J , Martin C , Preston I (1997) Bibliographic databases in psychiatry: an overview. Psychiatr Bull 21: 578–580

Oxman A , Cook D J Guyatt G H , for the evidence-based working group (1994) Users' guidelines to the medical literature VI How to use an overview. JAMA 272: 1367–1371

Sackett D L , Richardson W S , Rosenberg W et al. (1997) Evidencebased medicine. NewYork: Churchill Livingstone

Song F (1997) Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials. J Psychopharmacol 11: 65–71

Warner J P (1999) Evidence-based psychopharmacology 1. Appraising a single therapeutic trial: what is the evidence for treating early Alzheimer's disease with donepezil? J Psychopharmacol 13: 308–312